The FDA announced first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
On Jun. 23, 2020, the FDA launched Project Patient Voice, an initiative of the FDAï¾’s Oncology Center of…
FDA approved HPV vaccine Gardasil as throat cancer prevention
On Jun. 12, 2020, the FDA announced it had approved an expanded indication for Merck’s GARDASIL9 for the…
NIH scientists developed blood test to help improve liver cancer screening
On Jun. 11, 2020, scientists announced the development of a new test that can help identify people who…
Disease | Life Science News | NIH | Oncology
NIH study linked cigarette smoking to higher stroke risk in African Americans
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
Innovent and Roche enter into strategic collaboration to discover and develop cellular therapies and bispecific antibodies
On Jun. 8, 2020, Innovent Biologics announced a strategic research and development collaboration with Roche covering multiple cell…
Study identified potential approach to treat severe respiratory distress in patients with COVID-19
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
Gilead and Arcus Biosciences established 10-year partnership to co-develop and co-commercialize next-generation cancer immunotherapies
On May 27, 2020, Gilead Sciences and Arcus Biosciences announced that the companies had entered into a 10-year…
AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…
FDA approved first targeted therapy to treat aggressive form of lung cancer
On May 7, 2020, the FDA approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell…
Cancer patients face high mortality from COVID-19
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
CTI Biopharma announced initiation of phase 3 PRE-VENT study evaluating Pacritinib in hospitalized patients with severe COVID-19
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
FDA approved new therapy for triple negative breast cancer that has spread, not responded to other treatments
On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Immunomedics’ Trodelvy (sacituzumab…
The FDA approved new therapy for triple negative breast cancer
On Apr. 22, 2020, the FDA granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy), developed by Immunomedics, for the…
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
SeaGen announced FDA approval of TUKYSA (tucatinib) for people with advanced metastatic HER2-positive breast cancer
On Apr. 17, 2020, Seagen announced the FDA granted approval to TUKYSA (tucatinib) tablets in combination with trastuzumab…
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
MediciNova announced plans to initiate a clinical trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
FDA approved BRAFTOVIï¾® (Encorafenib) in combination with Cetuximab for treatment of BRAFV600E-mutant metastatic colorectal cancer
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIï¾® (encorafenib) in combination with cetuximab (marketed…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
Roswell Park’s Dr. Pawel Kalinski lead $145 million NCI-funded immunotherapy effort
On Mar. 31, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyï¾’s Hong Kong subsidiary, Pangu BioPharma, together with…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
UMN Institute scientist links ancient virus to cancer risk
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…